Erratum: Stepwise orthogonal click chemistry toward fabrication of paclitaxel/galactose functionalized fluorescent nanoparticles for HepG2 cell targeting and delivery (Bioconjugate Chemistry (2013) 24 (1698-1709) DOI:10.1021/bc400219t);Stepwise orthogonal click chemistry toward fabrication of paclitaxel/galactose functionalized fluorescent nanoparticles for hepg2 cell targeting and delivery

Bioconjugate Chemistry

Volumn 24, Issue 10, 2013, Pages 1698-1709

  Lai, Chian Hui ^a   Chang, Tsung Che ^a   Chuang, Yung Jen ^a   Tzou, Der Lii ^b   Lin, Chun Cheng ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COPPER COMPOUNDS; CYCLOADDITION; CYTOLOGY; FABRICATION; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HYDROCARBONS; LIGANDS; MOLECULES; SILICON COMPOUNDS; SILICON OXIDES; SYNTHESIS (CHEMICAL);

ANTICANCER DRUG; AZIDE-ALKYNE CYCLOADDITION; CELL DELIVERY; CELL TARGETING; CLICK CHEMISTRY; FLUORESCENT NANOPARTICLES; FUNCTIONALIZED; HEP-G2 CELLS; PACLITAXEL; TRIVALENTS;

NANOPARTICLES;

AMINE; AZIDE; COPPER; GALACTOSE; MAGNETIC NANOPARTICLE; NANOPARTICLE; PACLITAXEL; SILICON DIOXIDE; WATER;

ARTICLE; CATALYSIS; CELL KILLING; CELL PROLIFERATION; CELL STRUCTURE; CLICK CHEMISTRY; CONTROLLED STUDY; CYCLOADDITION; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; HUMAN CELL; INTERNALIZATION; MICROTUBULE; MICROWAVE RADIATION; NANOFABRICATION; SOLUBILITY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CLICK CHEMISTRY; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; GALACTOSE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NANOPARTICLES; PACLITAXEL;

EID: 84886017978     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc4005188     Document Type: Erratum

References (60)

1. Ferrari, M. (2005) Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5, 161-171
2. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., and Langer, R. (2007) Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2, 751-760
3. Davis, M. E., Chen, Z., and Shin, D. M. (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 7, 771-782
4. Doane, T. L. and Burda, C. (2012) The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy Chem. Soc. Rev. 41, 2885-2911
5. Xie, J., Lee, S., and Chen, X. (2010) Nanoparticle-based theranostic agents Adv. Drug Delivery Rev. 62, 1064-1079
6. Lin, C. C., Yeh, Y. C., Yang, C. Y., Chen, C. L., Chen, G. F., Chen, C. C., and Wu, Y. C. (2002) Selective binding of mannose-encapsulated gold Nanoparticles to type 1 Pili in Escherichia coli J. Am. Chem. Soc. 124, 3508-3509
7. Marradi, M., Chiodo, F., Garcia, I., and Penadés, S. (2013) Glyconanoparticles as multifunctional and multimodal carbohydrate systems Chem. Soc. Rev. 42, 4728-4745
8. Lai, C.-H., Lin, C.-Y., Wu, H.-T., Chan, H.-S., Chuang, Y.-J., Chen, C.-T., and Lin, C.-C. (2010) Galactose encapsulated multifunctional nanoparticle for HepG2 cell internalization Adv. Funct. Mater. 20, 3948-3958
9. Chien, W.-T., Yu, C.-C., Liang, C.-F., Lai, C.-H., Lin, P.-C., and Lin, C.-C. (2011) Functionalized Glyconanoparticles for the Study of Glycobiology. In Petite and Sweet: Glyco-Nanotechnology as a Bridge to New Medicines, pp 15-36, Chapter 2, American Chemical Society.
10. Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., and Josephson, L. (2006) Multivalent effects of RGD peptides obtained by nanoparticle display J. Med. Chem. 49, 6087-6093
11. Hong, S., Leroueil, P., Majoros, I. J., Orr, B. G., Baker, J. R., and Holl, M. M. B. (2007) The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform Chem. Biol. 14, 107-115
12. Ruoslahti, E., Bhatia, S. N., and Sailor, M. J. (2010) Targeting of drugs and nanoparticles to tumors J. Cell Biol. 188, 759-768
13. Hawkins, M. J., Soon-Shiong, P., and Desai, N. (2008) Protein nanoparticles as drug carriers in clinical medicine Adv. Drug Delivery Rev. 60, 876-885
14. Adiseshaiah, P. P., Hall, J. B., and McNeil, S. E. (2010) Nanomaterial standards for efficacy and toxicity assessment Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2, 99-112
15. van Blaaderen, A. and Vrij, A. (1992) Synthesis and characterization of colloidal dispersions of fluorescent, monodisperse silica spheres Langmuir 8, 2921-2931
16. Ow, H., Larson, D. R., Srivastava, M., Baird, B. A., Webb, W. W., and Wiesner, U. (2005) Bright and stable core-shell fluorescent silica nanoparticles Nano Lett. 5, 113-117
17. Kim, S. H., Jeyakumar, M., and Katzenellenbogen, J. A. (2007) Dual-Mode Fluorophore-Doped Nickel Nitrilotriacetic Acid-Modified Silica Nanoparticles Combine Histidine-Tagged Protein Purification with Site-Specific Fluorophore Labeling J. Am. Chem. Soc. 129, 13254-13264
18. Yan, J., Estévez, M. C., Smith, J. E., Wang, K., He, X., Wang, Lin, and Tan, W. (2007) Dye-doped nanoparticles for bioanalysis Nano Today 2, 44-50
19. Bae, S. W., Tan, W., and Hong, J.-I. (2012) Fluorescent dye-doped silica nanoparticles: new tools for bioapplications Chem. Commun. 48, 2270-2282
20. Davies, G.-L., Barry, A., and Gun'ko, Y. K. (2009) Preparation and size optimization of silica nanoparticles using statistical analyses Chem. Phys. Lett. 468, 239-244
21. Stöber, W., Fink, A., and Bohn, E. (1968) Controlled growth of monodisperse silica spheres in the micron size range J. Colloid Interface Sci. 26, 62-69
22. Jiang, W., Kim, B. Y. S., Rutka, J. T., and Chan, W. C. W. (2008) Nanoparticle-mediated cellular response is size-dependent Nat. Nanotechnol. 3, 145-150
23. Fang, C., Shi, B., Pei, Y. Y., Hong, M. H., Wu, J., and Chen, H. Z. (2006) In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size Eur. J. Pharm. Sci. 27, 27-36
24. Zhao, X., Bagwe, R. P., and Tan, W. (2004) Development of organic-dye-doped silica nanospheres in a reverse microemulsion Adv. Mater. 16, 173-176
25. Dong, X., Mattingly, C. A., Tseng, M. T., Cho, M. J., Liu, Y., Adams, V. R., and Mumper, R. J. (2009) Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP Cancer Res. 69, 3918-3926
26. Lai, C.-H., Lin, Y.-C., Chou, F.-I., Liang, C.-F., Lin, E.-W., Chuang, Y.-J., and Lin, C.-C. (2012) Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy Chem. Commun. 48, 612-614
27. Gibson, J. D., Khanal, B. P., and Zubarev, E. R. (2007) Paclitaxel-functionalized gold nanoparticles J. Am. Chem. Soc. 129, 11653-11661
28. Hwu, J. R., Lin, Y. S., Josephrajan, T., Hsu, M.-H., Cheng, F.-Y., Yeh, C.-S., Su, W.-C., and Shieh, D.-B. (2008) Targeted paclitaxel by conjugation to iron oxide and gold nanoparticles J. Am. Chem. Soc. 131, 66-68
29. Chen, J., Chen, S., Zhao, X., Kuznetsova, L. V., Wong, S. S., and Ojima, I. (2008) functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery J. Am. Chem. Soc. 130, 16778-16785
30. Liu, K. K., Zheng, W. W., Wang, C. C., Chiu, Y. C., Cheng, C. L., Lo, Y. S., Chen, C., and Chao, J. I. (2010) Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy Nanotechnology 21, 315106
31. Chorny, M., Fishbein, I., Yellen, B. B., Alferiev, I. S., Bakay, M., Ganta, S., Adamo, R., Amiji, M., Friedman, G., and Levy, R. J. (2010) Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields Proc. Natl. Acad. Sci. U.S.A. 107, 8346-8351
32. Wang, Y., Wang, Y., Xiang, J., and Yao, K. (2010) Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles Biomacromolecules 11, 3531-3538
33. Zhang, X.-Q., Xu, X., Lam, R., Giljohann, D., Ho, D., and Mirkin, C. A. (2011) A strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates ACS Nano 5, 6962-6970
34. Mo, R., Jin, X., Li, N., Ju, C., Sun, M., Zhang, C., and Ping, Q. (2011) The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles Biomaterials 32, 4609-4620
35. Das, M., Bandyopadhyay, D., Mishra, D., Datir, S., Dhak, P., Jain, S., Maiti, T. K., Basak, A., and Pramanik, P. (2011) ″Clickable″, trifunctional magnetite nanoparticles and their chemoselective biofunctionalization Bioconjugate Chem. 22, 1181-1193
36. Shan, L., Cui, S., Du, C., Wan, S., Qian, Z., Achilefu, S., and Gu, Y. (2012) A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy Biomaterials 33, 146-162
37. Medarova, Z., Pham, W., Farrar, C., Petkova, V., and Moore, A. (2007) In vivo imaging of siRNA delivery and silencing in tumors Nat. Med. 13, 372-377
38. Lim, R. K. V. and Lin, Q. (2010) Bioorthogonal chemistry: recent progress and future directions Chem. Commun. 46, 1589-1600
39. Kele, P., Mezo, G., Achatz, D., and Wolfbeis, O. S. (2009) Dual labeling of biomolecules by using click chemistry: a sequential approach Angew. Chem., Int. Ed. 48, 344-347
40. Achatz, D. E., Mezo, G., Kele, P., and Wolfbeis, O. S. (2009) Probing the activity of matrix metalloproteinase II with a sequentially click-labeled silica nanoparticle FRET probe ChemBioChem 10, 2316-2320
41. Agard, N. J., Prescher, J. A., and Bertozzi, C. R. (2004) A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems J. Am. Chem. Soc. 126, 15046-15047
42. Agard, N. J., Baskin, J. M., Prescher, J. A., Lo, A., and Bertozzi, C. R. (2006) A comparative Study of bioorthogonal reactions with azides ACS Chem. Biol. 1, 644-648
43. Jewett, J. C. and Bertozzi, C. R. (2010) Cu-free click cycloaddition reactions in chemical biology Chem. Soc. Rev. 39, 1272-1279
44. Damascelli, B., Cantu, G., Mattavelli, F., Tamplenizza, P., Bidoli, P., Leo, E., Dosio, F., Cerrotta, A. M., Di Tolla, G., Frigerio, L. F., Garbagnati, F., Lanocita, R., Marchiano, A., Patelli, G., Spreafico, C., Ticha, V., Vespro, V., and Zunino, F. (2001) Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity Cancer 92, 2592-2602
45. Griset, A. P., Walpole, J., Liu, R., Gaffey, A., Colson, Y. L., and Grinstaff, M. W. (2009) Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system J. Am. Chem. Soc. 131, 2469-2471
46. Sundararajan, C., Besanger, T. R., Labiris, R., Guenther, K. J., Strack, T., Garafalo, R., Kawabata, T. T., Finco-Kent, D., Zubieta, J., Babich, J. W., and Valliant, J. F. (2010) Synthesis and characterization of rhenium and technetium-99m labeled insulin J. Med. Chem. 53, 2612-2621
47. Cavallaro, G., Licciardi, M., Caliceti, P., Salmaso, S., and Giammona, G. (2004) Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug Eur. J. Pharm. Biopharm. 58, 151-159
48. Kuzmin, A., Poloukhtine, A., Wolfert, M. A., and Popik, V. V. (2010) Surface functionalization using catalyst-free azide-alkyne cycloaddition Bioconjugate Chem. 21, 2076-2085
49. Schmitt, L., Dietrich, C., and Tampe, R. (1994) Synthesis and characterization of chelator-lipids for reversible immobilization of engineered proteins at self-assembled lipid interfaces J. Am. Chem. Soc. 116, 8485-8491
50. Chen, G., Song, F., Wang, X., Sun, S., Fan, J., and Peng, X. (2012) Bright and stable Cy3-encapsulated fluorescent silica nanoparticles with a large Stokes shift Dyes Pigm. 93, 1532-1537
51. Koehler, L. H. (1952) Differentiation of carbohydrates by anthrone reaction rate and color intensity Anal. Chem. 24, 1576-1579
52. Chien, Y. Y., Jan, M. D., Adak, A. K., Tzeng, H. C., Lin, Y. P., Chen, Y. J., Wang, K. T., Chen, C. T., Chen, C. C., and Lin, C. C. (2008) Globotriose-functionalized gold nanoparticles as multivalent probes for Shiga-like toxin ChemBioChem 9, 1100-1109
53. Tan, W., Wang, K., He, X., Zhao, X. J., Drake, T., Wang, L., and Bagwe, R. P. (2004) Bionanotechnology based on silica nanoparticles Med. Res. Rev. 24, 612-638
54. Wessendorf, M. W. and Brelje, T. C. (1992) Which fluorophore is brightest? A comparison of the staining obtained using fluorescein, tetramethylrhodamine, lissamine rhodamine, Texas red, and cyanine 3.18 Histochemistry 98, 81-85
55. Yu, C.-C., Kuo, Y.-Y., Liang, C.-F., Chien, W.-T., Wu, H.-T., Chang, T.-C., Jan, F.-D., and Lin, C.-C. (2012) Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis Bioconjugate Chem. 23, 714-724
56. Schiff, P. B. and Horwitz, S. B. (1980) Taxol stabilizes microtubules in mouse fibroblast cells Proc. Natl. Acad. Sci. U.S.A. 77, 1561-1565
57. Kavallaris, M. (2010) Microtubules and resistance to tubulin-binding agents Nat. Rev. Cancer 10, 194-204
58. Lin, Y. S., Tungpradit, R., Sinchaikul, S., An, F. M., Liu, D. Z., Phutrakul, S., and Chen, S. T. (2008) Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters J. Med. Chem. 51, 7428-7441
59. McAuliffe, G., Roberts, L., and Roberts, S. (2002) Paclitaxel administration and its effects on clinically relevant human cancer and non cancer cell lines Biotechnol. Lett. 24, 959-964
60. Gagandeep, S., Novikoff, P. M., Ott, M., and Gupta, S. (1999) Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines Cancer Lett. 136, 109-118